Singular Genomics Systems is a life science technology company that is utilizing next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians. Co. has developed a proprietary NGS technology, which it refers to as its Sequencing Engine. Co.'s primary product, the G4, targets the NGS market and is comprised of an instrument and associated menu of consumable kits. Co.'s second product in development, the PX, combines single-cell analysis, spatial analysis, genomics and proteomics in one integrated instrument to provide a versatile multiomics solution. The OMIC average annual return since 2021 is shown above.
The Average Annual Return on the OMIC average annual return since 2021 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether OMIC average annual return since 2021 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the OMIC average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|